Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication

被引:40
作者
Cherif, Honar [1 ]
Martling, Claes-Roland
Hansen, Jan
Kalin, Mats
Bjorkholm, Magnus
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Div Haematol, S-17176 Stockholm, Sweden
[2] Karolinska Univ Hosp, Karolinska Inst, Div Anesthesiol & Intens Care, S-17176 Stockholm, Sweden
[3] Karolinska Univ Hosp, Karolinska Inst, Div Emergency Med, S-17176 Stockholm, Sweden
[4] Karolinska Univ Hosp, Karolinska Inst, Div Infect Dis, S-17176 Stockholm, Sweden
关键词
intensive care; hematology; leukemia; long-term; outcome;
D O I
10.1007/s00520-007-0268-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Goal of work The admission of patients with hematological disorders to the intensive care unit (ICU) involves a complex resource usage and may be associated with high mortality. The decision making to transfer a severely ill patient to the ICU, therefore, presents an ethical dilemma. We assessed both early and long-term outcomes in relation to clinical characteristics with the aim to facilitate clinical decision making. Materials and methods We performed a cohort study of hematological patients admitted to ICU at a university hospital. Main results During a 6-year period (1996-2001), 85 patients with a median age of 59 years were admitted to ICU. The majority of patients (88%) suffered from hematological malignancies. Major reasons for ICU admission were respiratory failure (41%) and septic shock/pre-shock (24%). The median duration of ICU admission was 2 (1-67) days. Crude in-ICU, 30-day, and 6-month mortality rates were 30, 49, and 62%, respectively. Overall 5-year survival rate was 20%, and 13 (15%) patients were alive at time of follow-up (median 7.4 years). Respiratory failure requiring ventilatory support and a high Acute Physiology and Chronic Health Evaluation II score was significantly correlated to high in-ICU mortality, but not to long-term outcome. Type of hematological malignancy, neutropenia, thrombocytopenia, bacteremia, prior administration of chemotherapy, age, or gender was not significantly associated with outcome. Conclusions The current study provides encouraging results on long-term post-ICU outcome also in elderly patients with hematological diseases. For a substantial proportion of critically ill hematological patients, a short time care at an ICU is lifesaving. These patients should be offered intensive care unless or until it is clear that there is little prospect of recovery from the acute illness or that the underlying malignancy cannot be controlled.
引用
收藏
页码:1393 / 1398
页数:6
相关论文
共 32 条
[1]   Determinants of postintensive care unit mortality: A prospective multicenter study [J].
Azoulay, E ;
Adrie, C ;
De Lassence, A ;
Pochard, F ;
Moreau, D ;
Thiery, G ;
Cheval, C ;
Moine, P ;
Garrouste-Orgeas, M ;
Alberti, C ;
Cohen, Y ;
Timsit, JF .
CRITICAL CARE MEDICINE, 2003, 31 (02) :428-432
[2]   Improved survival in cancer patients requiring mechanical ventilatory support: Impact of noninvasive mechanical ventilatory support [J].
Azoulay, E ;
Alberti, C ;
Bornstain, C ;
Leleu, G ;
Moreau, D ;
Recher, C ;
Chevret, S ;
Le Gall, JR ;
Brochard, L ;
Schlemmer, B .
CRITICAL CARE MEDICINE, 2001, 29 (03) :519-525
[3]   Predictors of short-term mortality in critically ill patients with solid malignancies [J].
Azoulay, E ;
Moreau, D ;
Alberti, C ;
Leleu, G ;
Adrie, C ;
Barboteu, M ;
Cottu, P ;
Levy, V ;
Le Gall, JR ;
Schlemmer, B .
INTENSIVE CARE MEDICINE, 2000, 26 (12) :1817-1823
[4]   Changing use of intensive care for hematological patients: the example of multiple myeloma [J].
Azoulay, E ;
Recher, C ;
Alberti, C ;
Soufir, L ;
Leleu, G ;
Le Gall, JR ;
Fermand, JP ;
Schlemmer, B .
INTENSIVE CARE MEDICINE, 1999, 25 (12) :1395-1401
[5]   Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication [J].
Benoit, DD ;
Vandewoude, KH ;
Decruyenaere, JM ;
Hoste, EA ;
Colardyn, FA .
CRITICAL CARE MEDICINE, 2003, 31 (01) :104-112
[6]   Prognostic factors for neutropenic patients in an intensive care unit: Respective roles of underlying malignancies and acute organ failures [J].
Blot, F ;
Guiguet, M ;
Nitenberg, G ;
Leclercq, B ;
Gachot, B ;
Escudier, B .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (07) :1031-1037
[7]   Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care [J].
Cornet, AD ;
Issa, AI ;
van de Loosdrecht, AA ;
Ossenkoppele, GJ ;
van Schijndel, RJMS ;
Groeneveld, ABJ .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (06) :511-516
[8]   MECHANICAL VENTILATION AFTER MARROW TRANSPLANTATION - RISK-FACTORS AND CLINICAL OUTCOME [J].
CRAWFORD, SW ;
SCHWARTZ, DA ;
PETERSEN, FB ;
CLARK, JG .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (03) :682-687
[9]   Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients [J].
Darmon, M ;
Azoulay, E ;
Alberti, C ;
Fieux, F ;
Moureau, D ;
Le Gall, JR ;
Schlemmer, B .
INTENSIVE CARE MEDICINE, 2002, 28 (12) :1775-1780
[10]  
Epner DE, 1996, J INVEST MED, V44, P254